Publicaciones en las que colabora con Berta Cillero Pastor (23)

2021

  1. Identification of a distinct lipidomic profile in the osteoarthritic synovial membrane by mass spectrometry imaging

    Osteoarthritis and Cartilage, Vol. 29, Núm. 5, pp. 750-761

2020

  1. Integrative metabolic pathway analysis reveals novel therapeutic targets in osteoarthritis

    Molecular and Cellular Proteomics, Vol. 19, Núm. 4, pp. 574-588

2017

  1. MALDI mass spectrometry imaging in rheumatic diseases

    Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1865, Núm. 7, pp. 784-794

2015

  1. Characterization of lipidic markers of chondrogenic differentiation using mass spectrometry imaging

    Proteomics, Vol. 15, Núm. 4, pp. 702-713

  2. Protein classification and distribution in osteoarthritic human synovial tissue by matrix-assisted laser desorption ionization mass spectrometry imaging

    Analytical and bioanalytical chemistry, Vol. 407, Núm. 8, pp. 2213-2222

2013

  1. Matrix-assisted laser desorption ionization-imaging mass spectrometry: A new methodology to study human osteoarthritic cartilage

    Arthritis and Rheumatism, Vol. 65, Núm. 3, pp. 710-720

  2. Mitochondrial respiratory chain dysfunction modulates metalloproteases -1, -3 and -13 in human normal chondrocytes in culture

    BMC Musculoskeletal Disorders, Vol. 14

2012

  1. Dimethylarginine dimethylaminohydrolase 2, a newly identified mitochondrial protein modulating nitric oxide synthesis in normal human chondrocytes

    Arthritis and Rheumatism, Vol. 64, Núm. 1, pp. 204-212

  2. Time-of-flight secondary ion mass spectrometry-based molecular distribution distinguishing healthy and osteoarthritic human cartilage

    Analytical Chemistry, Vol. 84, Núm. 21, pp. 8909-8916

2011

  1. Effect of nitric oxide on mitochondrial activity of human synovial cells

    BMC Musculoskeletal Disorders, Vol. 12

2010

  1. Proteomic analysis by two-dimensional electrophoresis to identify the normal human chondrocyte proteome stimulated by tumor necrosis factor α and interleukin-1 β

    Arthritis and Rheumatism, Vol. 62, Núm. 3, pp. 802-814

2009

  1. Evaluation of chondroprotective effect of glucosamine and chondroitin sulfate by a proteomic approach

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 157-157

2008

  1. Anti-apoptotic effect of transforming growth factor-β1 on human articular chondrocytes: role of protein phosphatase 2A

    Osteoarthritis and Cartilage, Vol. 16, Núm. 11, pp. 1370-1378

  2. Análisis proteómico bidimesional del condrocito humano normal bajo el efecto de IL-1β y TNF-α

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 1, pp. 83-83

  3. Differential effects of tumor necrosis factor-α and interleukin-1β on cell death in human articular chondrocytes

    Osteoarthritis and Cartilage, Vol. 16, Núm. 6, pp. 715-722

  4. Identificacion de proteínas que interaccionan con la subunidad catalítica de la fosfatasa 2A en condrocitos artrósicos y normales

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 1, pp. 87-87

  5. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes

    Arthritis and Rheumatism, Vol. 58, Núm. 8, pp. 2409-2419

2007

  1. Evidencia de mecanismos inflamatorios en la osteoartritis

    Reumatologia Clinica, Vol. 3, Núm. EXTRA 3, pp. 23-27

2006

  1. Cytokines, tumor necrosis factor-α and interleukin-1β, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes

    Osteoarthritis and Cartilage, Vol. 14, Núm. 7, pp. 660-669

  2. Mitochondrial activity is modulated by TNFα and IL-1β in normal human chondrocyte cells

    Osteoarthritis and Cartilage, Vol. 14, Núm. 10, pp. 1011-1022